The Autism Symptom Dimensions Questionnaire: Development and psychometric evaluation of a new, open‐source measure of autism symptomatology von Frazier, Thomas W., Dimitropoulos, Anastasia, Abbeduto, Leonard, Armstrong‐Brine, Melissa, Kralovic, Shanna, Shih, Andy, Hardan, Antonio Y., Youngstrom, Eric A., Uljarević, Mirko, Speer, Leslie, Wagner, Kayla, West, Kortney, Uhlig, Rich

Volltext

Intel virtualization technology von Uhlig, R., Neiger, G., Rodgers, D., Santoni, A.L., Martins, F.C.M., Anderson, A.V., Bennett, S.M., Kagi, A., Leung, F.H., Smith, L.

Volltext

Taking Virtualization Mainstream on IntelŴArchitecture Platforms von Uhlig, Rich

Volltext

Thread-level parallelism and interactive performance of desktop applications von FLAUTNER, Krisztian, UHLIG, Rich, REINHARDT, Steve, MUDGE, Trevor

Volltext

Intel labs' Rich Uhlig: A new director for new computer architectures - [ResourcesQ&A]

Volltext

Thread-level parallelism and interactive performance of desktop applications von Flautner, Krisztián, Uhlig, Rich, Reinhardt, Steve, Mudge, Trevor

Volltext

Thread-level parallelism and interactive performance of desktop applications von Flautner, Kristián, Uhlig, Rich, Reinhardt, Steve, Mudge, Trevor

Volltext

Thread-level parallelism and interactive performance of desktop applications von Flautner, Kristian, Uhlig, Rich, Reinhardt, Steve, Mudge, Trevor

Volltext

Phase II Trial of Gefitinib in Recurrent Glioblastoma von Rich, Jeremy N, Reardon, David A, Peery, Terry, Dowell, Jeannette M, Quinn, Jennifer A, Penne, Kara L, Wikstrand, Carol J, Van Duyn, Lauren B, Dancey, Janet E, McLendon, Roger E, Kao, James C, Stenzel, Timothy T, Ahmed Rasheed, B K, Tourt-Uhlig, Sandra E, Herndon, 2nd, James E, Vredenburgh, James J, Sampson, John H, Friedman, Allan H, Bigner, Darell D, Friedman, Henry S

Volltext

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease von Thomas, Tom, Friedrich, Matthias, Rich-Griffin, Charlotte, Pohin, Mathilde, Agarwal, Devika, Pakpoor, Julia, Lee, Carl, Tandon, Ruchi, Rendek, Aniko, Aschenbrenner, Dominik, Jainarayanan, Ashwin, Voda, Alexandru, Siu, Jacqueline H. Y., Sanches-Peres, Raphael, Nee, Eloise, Sathananthan, Dharshan, Kotliar, Dylan, Todd, Peter, Kiourlappou, Maria, Gartner, Lisa, Ilott, Nicholas, Issa, Fadi, Hester, Joanna, Turner, Jason, Nayar, Saba, Mackerodt, Jonas, Zhang, Fan, Jonsson, Anna, Brenner, Michael, Raychaudhuri, Soumya, Kulicke, Ruth, Ramsdell, Danielle, Stransky, Nicolas, Pagliarini, Ray, Bielecki, Piotr, Spies, Noah, Marsden, Brian, Taylor, Stephen, Wagner, Allon, Klenerman, Paul, Walsh, Alissa, Coles, Mark, Jostins-Dean, Luke, Powrie, Fiona M., Filer, Andrew, Travis, Simon, Uhlig, Holm H., Dendrou, Calliope A., Buckley, Christopher D.

Volltext

629 A SINGLE-CELL THERAPEUTIC ATLAS OF ANTI-TUMOUR NECROSIS FACTOR THERAPY IN INFLAMMATORY BOWEL DISEASE von Thomas, Tom, Rich-Griffin, Charlotte, Pohin, Mathilde, Friedrich, Matthias, Kulicke, Ruth, Bielecki, Piotr, Spies, Noah, Travis, Simon P., Uhlig, Holm, Dendrou, Calliope, Buckley, Christopher D.

Volltext

Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma von REARDON, David A, QUINN, Jennifer A, PROVENZALE, James M, SAMPSON, John H, SMITH, Robert P, SWAISLAND, Alan J, OCHS, Judith S, LYONS, Peggy, TOURT-UHLIG, Sandy, BIGNER, Darell D, FRIEDMAN, Henry S, RICH, Jeremy N, VREDENBURGH, James J, GURURANGAN, Sridharan, FRIEDMAN, Allan H, DESJARDINS, Annick, SATHORNSUMETEE, Sith, HERNDON, James E, DOWELL, Jeannette M, MCLENDON, Roger E

Volltext

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma von QUINN, Jennifer A, REARDON, David A, AVGEROPOULOS, Nicholas, FINLAY, Jonathan, TOURT-UHLIG, Sandra, AFFRONTI, Mary Lou, EVANS, Brandon, STAFFORD-FOX, Valerie, ZAKNOEN, Sara, FRIEDMAN, Henry S, FRIEDMAN, Allan H, RICH, Jeremy N, SAMPSON, John H, PROVENZALE, James M, MCLENDON, Roger E, GURURANGAN, Sridharan, BIGNER, Darell D, HERNDON, James E

Volltext

Characterising the early inflammatory landscape of primary sclerosing cholangitis von Dendrou, Calli, Lynch, Kate, Curion, Fabiola, Rich-Griffin, Charlotte, Yeung, Hing-Yuen, Provine, Nicholas, Ilott, Nicholas, Ferry, Helen, Fryer, Eve, Uhlig, Holm, Chapman, Roger W.G., Keshav, Satish, Klenerman, Paul

Volltext

Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the... von Sampson, John H, Akabani, Gamal, Archer, Gary E, Bigner, Darell D, Berger, Mitchel S, Friedman, Allan H, Friedman, Henry S, Herndon, 2nd, James E, Kunwar, Sandeep, Marcus, Steve, McLendon, Roger E, Paolino, Alison, Penne, Kara, Provenzale, James, Quinn, Jennifer, Reardon, David A, Rich, Jeremy, Stenzel, Timothy, Tourt-Uhlig, Sandra, Wikstrand, Carol, Wong, Terence, Williams, Roger, Yuan, Fan, Zalutsky, Michael R, Pastan, Ira

Volltext

Phase I Trial of Temozolomide Plus O 6 -Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma von Quinn, Jennifer A., Desjardins, Annick, Weingart, Jon, Brem, Henry, Dolan, M. Eileen, Delaney, Shannon M., Vredenburgh, James, Rich, Jeremy, Friedman, Allan H., Reardon, David A., Sampson, John H., Pegg, Anthony E., Moschel, Robert C., Birch, Robert, McLendon, Roger E., Provenzale, James M., Gururangan, Sridharan, Dancey, Janet E., Maxwell, Jill, Tourt-Uhlig, Sandra, Herndon, James E., Bigner, Darell D., Friedman, Henry S.

Volltext

Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects von Takei, Riku, Cadzow, Murray, Markie, David, Bixley, Matt, Phipps-Green, Amanda, Major, Tanya J, Li, Changgui, Choi, Hyon K, Li, Zhiqiang, Hu, Hua, Guo, Hui, He, Meian, Shi, Yongyong, Stamp, Lisa K, Dalbeth, Nicola, Merriman, Tony R, Wei, Wen-Hua

Volltext

Phase II Trial of Carmustine Plus O 6 -Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma von Quinn, Jennifer A., Pluda, James, Dolan, M. Eileen, Delaney, Shannon, Kaplan, Richard, Rich, Jeremy N., Friedman, Allan H., Reardon, David A., Sampson, John H., Colvin, O. Michael, Haglund, Michael M., Pegg, Anthony E., Moschel, Robert C., McLendon, Roger E., Provenzale, James M., Gururangan, Sridharan, Tourt-Uhlig, Sandra, Herndon, James E., Bigner, Darell D., Friedman, Henry S.

Volltext

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma von Quinn, Jennifer A, Pluda, James, Dolan, M Eileen, Delaney, Shannon, Kaplan, Richard, Rich, Jeremy N, Friedman, Allan H, Reardon, David A, Sampson, John H, Colvin, O Michael, Haglund, Michael M, Pegg, Anthony E, Moschel, Robert C, McLendon, Roger E, Provenzale, James M, Gururangan, Sridharan, Tourt-Uhlig, Sandra, Herndon, 2nd, James E, Bigner, Darell D, Friedman, Henry S

Volltext

Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma von Reardon, David A, Quinn, Jennifer A, Rich, Jeremy N, Gururangan, Sridharan, Vredenburgh, James, Sampson, John H, Provenzale, James M, Walker, Amy, Badruddoja, Michael, Tourt-Uhlig, Sandra, Herndon, 2nd, James E, Dowell, Jeannette M, Affronti, Mary Lou, Jackson, Susanne, Allen, Deborah, Ziegler, Karen, Silverman, Steven, Bohlin, Cindy, Friedman, Allan H, Bigner, Darell D, Friedman, Henry S

Volltext